March 28, 2023 8:28 PM
Latest:
  • Canada Set To Implement Stock Buyback Tax On Jan 1, 2024
  • Arkansas Proclaims ‘The Right To Keep and Bear Arms Day’ on the Day of Nashville Shooting
  • Is Amazon Considering An AMC Theatre Acquisition?
  • Elon Musk’s Neuralink Begins Search for Human Trials Partner
  • Only Tweets From Twitter Blue Accounts Will Be In The ‘For You’ Recommendations Beginning April 15
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Thank you!

You have successfully joined our subscriber list.

.

  • Home
  • Latest
    • Automotive
    • Briefing
    • Cannabis
    • Commentary
    • Education
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Psychedelics
    • Resources
    • Technology
  • Cannabis
  • Technology
  • Company Profiles
    • Hemlo Explorers
    • HydroGraph Clean Power
    • Power Nickel
    • Prime Meridian Resources
    • Riverside Resources
    • RooGold Inc
    • Slave Lake Zinc
    • Spey Resources
    • Trillion Energy
    • Vortex Metals
  • Resources
  • About
  • Contact Us
  • Advertise With Us

Revive Therapeutics

Biotech Briefing 

Revive Therapeutics Announces Final Stages In Bucillamine Phase 3 Clinical Trial For COVID-19

January 19, 2022 9:28 AMJanuary 19, 2022 9:04 AM ER Velasco 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) provided on Tuesday updates regarding the phase 3 clinical trial for oral drug bucillamine as a treatment

Share
Tweet
Share
Read more
Biotech Briefing 

Revive Therapeutics Adds Turkish Subjects To Bucillamine Phase 3 Clinical Trial For COVID-19

December 30, 2021 12:49 PMDecember 30, 2021 9:12 AM ER Velasco 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) announced on Wednesday that it has expanded its phase 3 clinical trial for oral drug bucillamine as

Share
Tweet
Share
Read more
Briefing Healthcare 

Revive Therapeutics Includes Treating Omicron Variant In Bucillamine Research

December 3, 2021 2:56 PMDecember 3, 2021 9:29 AM ER Velasco 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) announced today that it is expanding its research on oral drug Bucillamine. The firm decided to include

Share
Tweet
Share
Read more
Biotech Briefing Psychedelics 

Revive Therapeutics Announces Research Collaboration Agreement For Psilocybin Microneedle Patch

November 3, 2021 9:29 AMNovember 3, 2021 8:54 AM ER Velasco 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) announced today that it has entered into a research collaboration agreement with PharmaTher Holdings Ltd. (CSE: PHRM).

Share
Tweet
Share
Read more
Biotech Briefing 

Revive Therapeutics Enters Exclusive License For Ganoderma Lucidum Intellectual Property

August 18, 2021 9:23 AMAugust 18, 2021 9:23 AM Jay Lutz 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) last night announced that it has has entered into an exclusive licensing agreement. The licensing agreement

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Revive Therapeutics Provides Update On Current Psilocybin Programs

August 10, 2021 8:36 AMAugust 10, 2021 8:36 AM Jay Lutz 0 Comments Psilocybin, Revive Therapeutics

Revive Therapeutics (CSE: RVV) this morning provided a corporate update as it pertains to its psychedelic assets. The update primarily

Share
Tweet
Share
Read more
Biotech Briefing News 

Revive Therapeutics Begins Laying Groundwork For Commercialization Of Bucillamine

July 15, 2021 2:27 PMJuly 15, 2021 2:27 PM Jay Lutz 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) this afternoon reported that it is in the process of pursuing a commercialization plan for the

Share
Tweet
Share
Read more
Briefing News Psychedelics 

Revive Therapeutics Partners With University of Health Sciences Antigua To Further Psychedelics Research

June 17, 2021 8:45 AMJune 17, 2021 8:45 AM Jay Lutz 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) this morning announced that it has entered into a collaboration to further advance its psychedelic-assisted therapies.

Share
Tweet
Share
Read more
Briefing Healthcare News 

Revive Therapeutics Looks To Bring Bucillamine To India

June 8, 2021 9:15 AMJune 8, 2021 9:15 AM Jay Lutz 0 Comments Revive Therapeutics

Revive Therapeutics (CSE: RVV) is looking to India. The company this morning indicated that it has entered into a memorandum

Share
Tweet
Share
Read more
Briefing Healthcare News 

Revive Therapeutics Partners With UCSF To Study Bucillamine For Severe COVID-19

May 3, 2021 9:24 AMMay 3, 2021 9:24 AM Jay Lutz 0 Comments COVID-19, Revive Therapeutics

Revive Therapeutics (CSE: RVV) this morning had a major announcement, in that it has entered into a sponsored research agreement

Share
Tweet
Share
Read more
  • ← Previous

Briefings

Canada Set To Implement Stock Buyback Tax On Jan 1, 2024
Briefing Macro 

Canada Set To Implement Stock Buyback Tax On Jan 1, 2024

March 28, 2023 5:34 PM Jay Lutz 0

The Canadian government is finally set to implement a tax on share buybacks, as announced originally in 2022. Within its

Arkansas Proclaims ‘The Right To Keep and Bear Arms Day’ on the Day of Nashville Shooting
Briefing News 

Arkansas Proclaims ‘The Right To Keep and Bear Arms Day’ on the Day of Nashville Shooting

March 28, 2023 4:42 PM JP Alegre 0
Is Amazon Considering An AMC Theatre Acquisition?
Briefing Entertainment 

Is Amazon Considering An AMC Theatre Acquisition?

March 28, 2023 4:28 PM Hermina Paull 0
Elon Musk’s Neuralink Begins Search for Human Trials Partner
Biotech Briefing 

Elon Musk’s Neuralink Begins Search for Human Trials Partner

March 28, 2023 4:07 PM JP Alegre 0
Only Tweets From Twitter Blue Accounts Will Be In The ‘For You’ Recommendations Beginning April 15
Briefing Technology 

Only Tweets From Twitter Blue Accounts Will Be In The ‘For You’ Recommendations Beginning April 15

March 28, 2023 3:25 PM JP Alegre 0
French Investigators Raid 5 Major banks Over Suspected Tax Fraud, Money Laundering
Briefing Macro 

French Investigators Raid 5 Major banks Over Suspected Tax Fraud, Money Laundering

March 28, 2023 2:55 PM Hermina Paull 0
Cat Videos Prevent Expansion of Norwegian Munitions Factory
Briefing Energy 

Cat Videos Prevent Expansion of Norwegian Munitions Factory

March 28, 2023 2:18 PM JP Alegre 0

Spotlight Series

Jeffrey Christian: No, The World Isn’t Moving Away From The Dollar
Briefing Macro Video Series 

Jeffrey Christian: No, The World Isn’t Moving Away From The Dollar

March 28, 2023 1:30 PM Jay Lutz 0

Joining SmallCapSteve today is Jeffrey Christian, founder & managing director of the CPM Group. In this interview, we dive into

News

Arkansas Proclaims ‘The Right To Keep and Bear Arms Day’ on the Day of Nashville Shooting
Briefing News 

Arkansas Proclaims ‘The Right To Keep and Bear Arms Day’ on the Day of Nashville Shooting

March 28, 2023 4:42 PM JP Alegre 0

In a poorly-timed turn of events, the Arkansas House adopted House Resolution 1041, or ‘The Right To Keep and Bear

First Phosphate Enters Licensing Agreement For LFP Production Tech
Briefing News Resources 

First Phosphate Enters Licensing Agreement For LFP Production Tech

March 28, 2023 12:57 PM Jay Lutz 0
Trillion Energy Places Third Well In Multi-Well Development Program Into Production
Briefing Energy News 

Trillion Energy Places Third Well In Multi-Well Development Program Into Production

March 28, 2023 11:13 AM Jay Lutz 0
Heritage Mining Obtains Permits For Planned 3,600 Metre Drill Program
Briefing News Resources 

Heritage Mining Obtains Permits For Planned 3,600 Metre Drill Program

March 27, 2023 9:37 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Blockchain
  • Bonds
  • Briefing
  • Cannabis
  • Commentary
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2023 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.